跳至主要内容
临床试验/IRCT20211208053331N1
IRCT20211208053331N1已完成2 期

Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticism

Ahvaz University of Medical Sciences0 个研究点目标入组 172 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
24 years 至 45 years(—)
性别
All

入选标准

  • Neuroticism traits based on NEO-60 questionnaire with a score higher than 24
  • ?Age-range 24-45 years old
  • Obtaining informed consent from the individuals

排除标准

  • Pregnancy or intention to conceive
  • Presence of psychiatric disorder based on GHQ questionnaire with a score above 23
  • Previous history of SSRI antidepressant intolerance
  • Patients with severe side effects of citalopram
  • Patients with a history of chronic diseases such as brain and heart disease, vascular, seizures
  • People with a history of drug abuse.

研究者

相似试验